Abbott Laboratories (NYSE:ABT) shares, rose in value, with the stock price up by 0.40% to the previous day’s close as strong demand from buyers drove the stock to $134.54.
Actively observing the price movement in the recent trading, the stock is buoying the session at $134.00. The PE ratio was 17.45 over 12-month period. Referring to stock’s 52-week performance, its high was $141.23, and the low was $99.71. On the whole, ABT has fluctuated by 5.90% over the past month.
With the market capitalization of Abbott Laboratories currently standing at about $234.08 billion, investors are eagerly awaiting this quarter’s results, scheduled for in June. The company’s Forward Dividend Ratio is 2.28, with its dividend yield at 1.69%.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 44.61B, with a low estimate of 10.38B and a high estimate of 11.13B. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 11.01B.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that ABT’s technical picture suggests that short-term indicators denote the stock is a 100% Buy on average. However, medium-term indicators have put the stock in the category of 100% Buy while long-term indicators on average have been pointing out that it is a 100% Buy.
The stock’s technical analysis shows that the PEG ratio is about 1.69, with the price of ABT currently trading nearly 2.94% and 3.09% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 62.99, while the 7-day volatility ratio is showing 2.15% which for the 30-day chart, stands at 2.59%. Furthermore, Abbott Laboratories (ABT)’s beta value is 0.74, and its average true range (ATR) is 3.10.
A comparison of Abbott Laboratories (ABT) with its peers suggests the former has fared considerably weaker in the market. ABT showed an intraday change of 0.40% in today’s session so far, and over the past year, it grew by 26.72%%.
Data on historical trading for Abbott Laboratories (NYSE:ABT) indicates that the trading volumes over the past 3 months, they’ve averaged 7.06 million. According to company’s latest data on outstanding shares, there are 1.74 billion shares outstanding.
Nearly 0.67% of Abbott Laboratories’s shares belong to company insiders and institutional investors own 78.71% of the company’s shares. The stock has risen by 18.95% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the ABT stock heading into the next quarter.
